Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2007-07-12

Clinical Trial Update: The Effect of 5-FU and LMW Heparin on the Rate of Retinal Redetachment After Silicone Oil Removal in Cases of PVR [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial is evaluating whether 5-fluorouracil and low molecular weight heparin can reduce retinal redetachment after silicone oil removal in pro…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • 5-Fluorouracil (5-FU)
  • Low molecular weight heparin (low molecular weight heparin)

Snippet

Sponsor: Shahid Beheshti University of Medical Sciences | Conditions: Proliferative Vitreoretinopathy | Phase 3 | Status: UNKNOWN